PROPYLPARABEN

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
180.0 2.0 1 3 47.0 3 0.3
CAS
94133
UNII
Z8IX2SC1OH
SYNONYMS
ZINC ID(s)
Availability
Present in 63 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Functions of Propylparaben

Pres - Chemical preservative
PROPYLPARABEN

Dosages

Route Formulation Per Unit Dose
An,infiltration Injection 0.01%
Auricular (otic) Suspension 0.001%
Buccal Film 0.22MG
Buccal Film, Soluble 0.18MG
Im - Iv Injectable 0.02%
Im - Iv Injection 0.2%
Im - Iv Powder, For Injection Solution 0.04%
Im - Iv Solution 0.02%
Im - Iv - Sc Injection 20%
Im - Sc Injection 0.02%
Intra-Arterial Injection
Intra-Articular Injection 0.16%
Intrabursal Injection 0.02%
Intralesional Injection 0.02%
Intramuscular Injection 0.16%
Intramuscular Solution, Injection
Intramuscular Suspension 0.02%
Intramuscular Suspension, Injection 0.02%
Intrasynovial Injection
Intratumor Injection 0.02%
Intravascular Injection 0.03%
Intravenous Injectable 0.02%
Intravenous Injection 0.1%
Intravenous Liquid, Water, Sterile, For Injection 0.02%
Intravenous Powder, For Injection Solution 0.08%
Intravenous Solution, Injection 0.02%
Iv - Sc Injection 0.02%
Iv(infusion) Injection 0.06%
Iv(infusion) Powder, For Injection Solution 0.04%
N/a Liquid 0.01%
N/a Not Applicable 0.06MG
Nasal Solution 0.02%
Nasal Solution, Spray 0.02%
Nasal Spray, Metered 0.3%
Nerve Block Injection 0.04%
Ophthalmic Ointment 0.01%
Ophthalmic Solution 0.02%
Ophthalmic Solution, Drops 0.02%
Ophthalmic Suspension 0.01%
Ophthalmic Suspension, Drops 0.01%
Oral Capsule 0.21MG
Oral Capsule (immed./comp. Release), Soft Gelatin, Perle 0.08MG
Oral Capsule, Coated, Soft Gelatin 0.05MG
Oral Capsule, Hard Gelatin
Oral Capsule, Soft Gelatin 0.12MG
Oral Capsule, Sustained Action 0.22MG
Oral Concentrate 0.05%
Oral Drops
Oral Emulsion
Oral Liquid 0.02%
Oral Powder, For Oral Solution 0.03%W/W
Oral Powder, For Oral Suspension 0.08%W/W
Oral Powder, For Solution 0.02%
Oral Powder, For Suspension 0.08%
Oral Solution 10%
Oral Solution, Concentrate 0.02%
Oral Solution, Elixir 0.02%
Oral Solution, Liquid 0.02%
Oral Solution, Syrup 0.1%
Oral Suspension 4%
Oral Suspension, Liquid 0.06%
Oral Suspension, Sustained Action 0.03%
Oral Syrup 36%
Oral Tablet 0.2MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 0.14MG
Oral Tablet, Coated 0.002MG
Oral Tablet, Film Coated 0.04MG
Oral Tablet, Sustained Action 0.12MG
Rectal Aerosol, Metered 0.01%
Rectal Liquid 0.02%
Rectal Solution 0.02%
Rectal Suspension 0.03%
Soft Tissue Injection 0.02%
Subcutaneous Injection 0.03%
Subcutaneous Suspension, Injection 0.02%
Topical Cream, Augmented 0.1%W/W
Topical Cream, Emulsion, Sustained Release 0.1%
Topical Emulsion 0.06%
Topical Emulsion, Aerosol Foam 0.01%
Topical Emulsion, Cream 5.25%
Topical Emulsion, Lotion 0.06%
Topical Film, Controlled Release
Topical Gel 0.05%
Topical Jelly 0.03%W/V
Topical Lotion 0.2%
Topical Ointment 0.2%
Topical Patch
Topical Patch, Controlled Release
Topical Shampoo 0.03%
Topical Solution 0.03%
Ureteral Solution
Urethral Injection 0.02%
Urethral Jelly 0.03%
Vaginal Emulsion, Cream 0.1%
Vaginal Gel 0.02%
Vaginal Suppository

More Information

Usage Over Time

Data provided by OpenFDA

Comments